Vitamin D

精彩内容网上药店市场进入快速发展期。米内网数据显示，2023年中国网上药店终端药品（化学药+中成药）销售额突破600亿元，持续双位数增长，处方药市占率稳居第一；5个超10亿品种领衔化学药产品TOP20，“治秃神药”米诺地尔酊成首个10亿品牌，东阳光药磷酸奥司他韦颗粒暴涨416%；10个独家品种跻身中成药品牌TOP20，华润、以岭、太极等上榜。突破600亿！处方药市占率稳居第一随着线上问诊购药业务的不断发展和线上医保支付渠道的打通、医院处方外流逐步放开，实体药店不断加大线上渠道布局，以互联网和移动终端购物方式为主的消费群体逐步形成，网上药店药品市场进入快速发展期。米内网数据显示，近年来中国网上药店终端药品（化学药+中成药）市场规模呈现高速增长态势，2023年销售额一举突破600亿元，同比增长28.46%，持续双位数增长。其中，化学药的市场份额超过60%，中成药占比超30%。中国网上药店终端化学药及中成药销售情况（单位：亿元）来源：米内网中国网上药店药品终端竞争格局Rx（处方药）产品是销售大户，连续5年市占率第一；OTC（非处方药）产品持续扩容，2022年、2023年市场份额都超过40%；双跨产品市场份额整体呈现下降趋势。中国网上药店终端处方药/非处方药/双跨品种分布情况（化学药+中成药）来源：米内网中国网上药店药品终端竞争格局化学药TOP20：5大超10亿品种领跑，“流感神药”暴涨416%化学药涵盖14个治疗大类，2023年销售额涨幅皆超过15%，全身用抗感染药物大涨48.99%。消化系统及代谢药以高达26.82%的市场份额位列第一，生殖泌尿系统和性激素类药物、皮肤病用药分别位列第二、第三，占比分别为15.89%、14.90%。值得一提的是，TOP3治疗大类合计市场份额已超过57%。2023年中国网上药店终端化学药治疗大类TOP5来源：米内网中国网上药店药品终端竞争格局产品TOP20中，西地那非、奥利司他、米诺地尔酊等网红药名列前茅；枸橼酸西地那非片、奥利司他胶囊、他达拉非片依次位列前三，销售额都超过16亿元；米诺地尔酊、盐酸达泊西汀片分别位列第四、第五，销售额皆为首次突破10亿元。2023年中国网上药店终端化学药TOP20产品来源：米内网中国网上药店药品终端竞争格局品牌TOP20中，浙江万晟药业的“治秃神药”米诺地尔酊再次蝉联第一，销售额超过12亿元，且是网上药店的首个10亿元大品牌；国控星鲨的维生素D滴剂连续三年位列第二，销售额超过8亿元；辉瑞的枸橼酸西地那非片位列第三，山东新时代药业的奥利司他胶囊位列第四。2023年中国网上药店终端化学药TOP20品牌来源：米内网中国网上药店药品终端竞争格局枸橼酸西地那非片、奥利司他胶囊分别有3个品牌上榜，他达拉非片则有2个品牌上榜。国产品牌有12个，进口品牌有8个，涉及辉瑞、阿斯利康、诺和诺德、拜耳等跨国制药巨头。从销售额变化上看，拜耳的复合维生素片大跌22.71%、安士制药的碳酸钙D3咀嚼片(Ⅲ)大跌13.21%，其余18个品牌销售额皆有不同程度的增长。5个品牌销售额涨逾100%，东阳光药的磷酸奥司他韦颗粒狂飙416.24%、武汉杰士邦的他达拉非片狂飙300.97%、山东新时代药业的奥利司他胶囊狂飙238.16%、中山万汉制药的奥利司他胶囊暴涨132.49%、诺和诺德的司美格鲁肽注射液暴涨123.21%。中成药TOP20：10个独家品种亮眼，华润、以岭、太极上榜中成药涵盖13个治疗大类，常见病、慢性病、男科疾病等中成药网购广泛，泌尿系统疾病用药、呼吸系统疾病用药、消化系统疾病用药依次位列前三，合计市场份额接近50%；补气补血类用药位列第四，近年来在网上药店市场持续扩容，2023年销售额首次突破20亿元。2023年中国网上药店终端中成药治疗大类格局来源：米内网中国网上药店药品终端竞争格局品牌TOP20中，片仔癀药业的片仔癀连续三年夺得“销冠”，销售额超过4亿元；东阿阿胶的复方阿胶浆、阿胶分别位列第二、第三；以岭药业的连花清瘟胶囊位列第四、健民集团的龙牡壮骨颗粒位列第五，销售额皆超过2亿元。2023年中国网上药店终端中成药TOP20品牌来源：米内网中国网上药店药品终端竞争格局20个品牌中有10个为独家品种，包括片仔癀药业的片仔癀、东阿阿胶的复方阿胶浆、以岭药业的连花清瘟胶囊、健民集团的龙牡壮骨颗粒、白云山陈李济的舒筋健腰丸、汇仁药业的肾宝片、丽彩甘肃西峰制药的补肺丸等。11个品牌销售额涨逾30%，其中长白山野生动物繁殖试验场的熊胆粉狂飙264.44%、东阿阿胶的复方阿胶浆暴涨103.7%、太极集团重庆涪陵制药的藿香正气口服液暴涨96.64%。此外，辽宁朝花药业的壮腰补肾丸、陕西功达制药的复方黄柏祛癣搽剂、江西半边天药业的补肾丸都在2023年发力线上渠道，实现销售快速放量。数据来源：米内网数据库注：米内网《中国网上药店药品终端竞争格局》，统计范围是：全国网上药店所有药品数据，包括天猫、京东等第三方平台及私域平台上所有网上药店药品数据；上述销售额以产品在网上药店的平均零售价计算。本文为原创稿件，转载请注明来源和作者，否则将追究侵权责任。投稿及报料请发邮件到872470254@qq.com稿件要求详询米内微信首页菜单栏商务及内容合作可联系QQ：412539092【分享、点赞、在看】点一点不失联哦

RAHWAY, N.J., April 3, 2024 /PRNewswire/ -- Three in four Americans use a dietary supplement. Yet despite their prevalence, some experts say greater attention should be paid to when supplements should – and shouldn't – be used. In a new editorial from MerckManuals.com, Laura Shane-McWhorter, PharmD, University of Utah College of Pharmacy, addresses some of the things to consider around dietary supplements. 1. Diet vs. daily pills In many cases, it may be better to adjust your diet and lifestyle rather than take a daily pill, says Shane-McWhorter. A varied and healthy diet may be a better way to obtain nutrients. For example, it's typically better to eat salmon or another healthy fish a few times a week than it is to take a fish oil or omega-3 fatty acid supplement, says Shane-McWhorter. 2. Regulation requirements A common critique of dietary supplements is that they're not regulated. That's not exactly true, says Shane-McWhorter. Dietary supplement makers are required to follow good manufacturing processes and should report adverse effects under the Consumer Protection Act. Still, manufacturers are not required to disclose information on all ingredients to consumers, and the Food & Drug Administration does not analyze products before they're marketed and sold. Bottom line: there is less oversight into what's actually going into a bottle of dietary supplements, when compared with prescription drugs and over-the-counter products. 3. Consider the category In general, certain categories of dietary supplements may be more harmful than others, says Shane-McWhorter. Products including weight loss supplements, anything promoting bodybuilding, or "men's health" (sexual performance aids) can be particularly risky. Still, Shane McWhorter adds other supplements like fish oil, vitamin D, folic acid, and zinc may be useful in certain settings. 4. Always consult an expert Before starting any dietary supplement, it's important to have a conversation with your doctor. Some supplements can interact with the effectiveness and dosing of already-prescribed medications or treatments, among other concerns, says Shane-McWhorter. You can read more of Shane-McWhorter's advice on dietary supplements in this editorial on MerckManuals.com. About The Merck Manuals and MSD Manuals First published in 1899 as a small reference book for physicians and pharmacists, The Merck Manual grew in size and scope to become one of the world's most widely used comprehensive medical resources for professionals and consumers. As The Manual evolved, it continually expanded the reach and depth of its offerings to reflect the mission of providing the best medical information to a wide cross-section of users, including medical professionals and students, veterinarians and veterinary students, and consumers. In 2015, The Manuals kicked off Global Medical Knowledge 2020, a global initiative with the goal to make the best current medical information accessible by up to three billion professionals and patients around the world by 2020. The Manuals achieved that goal, and today its medical information is available in nearly 250 countries and in 14 languages. It's continuing its ambitious mission through outreach, education and creating new reliable medical resources. For access to thousands of medical topics with images, videos and a constantly expanding set of resources, visit MerckManuals.com or MSDManuals.com and connect with us on social media: For Consumers in the U.S. and its territories: X (formerly Twitter) and Facebook. For Professionals in the U.S. and its territories: X (formerly Twitter) and Facebook About Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn. SOURCE The Merck Manuals